Express Scripts CEO addresses drug pricing ‘misinformation’ image

St. Louis Post-Dispatch, February 17, 2017
Samantha Liss, quoting Rachel E. Sachs (Academic Fellow Alumna)

Links

Read the Full Article

[...] Typically, after dispensing drugs to patients, a drug manufacturer will write Express Scripts a rebate check.

That timing can expose some patients, especially those with high deductibles, to the full cost of a drug, said Rachel Sachs, an associate professor of law at Washington University. She focuses on health law and food and drug regulation.

PBMs serve a function, Sachs said, but they are partly to blame for high drug costs. Ultimately, she said, there’s not a lot of transparency in how the rebates are passed through to patients. [...]

health care finance health law policy insurance pharmaceuticals public health rachel sachs regulation